Evaluation of lipid profile, malondialdehyde, hemoglobin and ferritin in Iraqi women with polycystic ovarian syndrome
DOI:
https://doi.org/10.15584/ejcem.2025.2.14Keywords:
age variable, body mass index, ferritin, lipid profile, polycystic ovarian syndromeAbstract
Introduction and aim. The concept of polycystic ovarian syndrome (PCOS) is defined as a biochemical complex statement that affects many young and adult females (single and married). This case presents a variety of medical and biological concerns related to the reproductive system. The aim of the study was to investigate and estimate the levels of the lipid profile, malondialdehyde, hemoglobin and ferritin in women with PCOS.
Material and methods. Blood samples were collected from 180 women who were divided into 100 PCOS patients and 80 healthy women according to the variables of age and body mass index. Triglycerides (TG) levels were measured in blood sera by spectrophotometric method, total cholesterol (TC) levels were estimated using enzymatic methods and the high-density lipoprotein (HDL) was determined by the HDL-phosphotungstic acid precipitation method.
Results. Total cholesterol, triglyceride, low-density lipoproteins, and very low-density lipoproteins recorded a highly significant increase (p<0.001) whereas high-density lipoproteins decreased significantly (p<0.001) in women with PCOS women when compared to the control group depending on age and body mass index variables. The results showed that hemoglobin, ferritin and malondialdehyde levels increased significantly (p<0.001) in female PCOS compared to the healthy group according to age and body mass index variables.
Conclusion. The importance of thorough medical management of PCOS includes minimizing oxidative stress, metabolic function, and lipid profiles for avoidance of chronic health conditions.
Downloads
References
Al-Akabi DF, Kata FS, Khosho EZ. Estimation of biochemical and immunological parameters alteration in women with polycystic ovary syndrome in Basrah governorate. European Journal of Biomedical and Pharmaceutical Sciences. 2019;6(5):607-611.
Naeem S, Abdulkareem N, Mahmoud A. A Biochemical Study of Infertile Women With and Without Polycystic Ovarian Syndrome in Basra City, Iraq. University of Thi-Qar Journal of Science. 2023;10(1(SI)):62-67. Doi: 10.32792/utq/utjsci/v10i1(si).968
Dumesic DA, Lobo RA. Cancer risk and PCOS. Steroids. 2013;78(8):782-785. doi: 10.1016/j.steroids.2013.04.004
Mahmud AA, Anu UH, Foysal KA, et al. Elevated serum malondialdehyde (MDA), insulin, follicle-stimulating hormone (FSH), luteinizing hormone (LH), and thyroid- stimulating hormone (TSH), and reduced antioxidant vitamins in polycystic ovarian syndrome patients. Narra J. 2022;2(1):e56. doi: 10.52225/narra.v2i1.56
Ko PC, Huang SY, Hsieh CH, Hsu MI, Hsu CS. Serum ferritin levels and polycystic ovary syndrome in obese and nonobese women. Taiwan J Obstet Gynecol. 2015;54(4):403-407. doi: 10.1016/j.tjog.2014.06.005
Papalou O, M. Victor V, Diamanti-Kandarakis E. Oxidative Stress in Polycystic Ovary Syndrome. Curr Pharma Des. 2016;22(18):2709-2722. doi: 10.2174/1381612822666160216151852
Al-Fartosy AJM, Awad NA, Mohammed AH. Intelectin-1 and Endocrinological Parameters in Women with Polycystic Ovary Syndrome: Effect of Insulin Resistance. Ewha Med J. 2020;43(1):1-11. doi: 10.12771/emj.2020.43.1.1
Shaheen N, Naz L, Maqsood A, Zehra N. Evaluation Of Clinical Course And Risk Factors For Polycystic Ovary Syndrome Among Married And Unmarried Women. Int J Bio Res. 2015;3(1): 53-56.
Diamanti-Kandarakis E, Kandarakis H, Legro RS. The Role of Genes and Environment in the Etiology of PCOS. Endocrine. 2006;30(1):19-26. doi: 10.1385/endo:30:1:19
Dïncer Y, Akcay T, Erdem T, Ilker Saygi˙li˙ E, Gundogdu S. DNA damage, DNA susceptibility to oxidation and glutathione level in women with polycystic ovary syndrome. Scand J Clin Lab Inves. 2005;65(8):721-728. doi: 10.1080/00365510500375263
Akre S, Sharma K, Chakole S, Wanjari MB. Recent advances in the management of polycystic ovary syndrome: A review article. Cureus. 2022;14(8):1-6. doi: 10.7759/cureus.27689
Tay CT, Garad R, Mousa A, Khomami MB, Joham A, Teede H. PCOS: international collaboration to translate evidence and guide future research. J Endocrinol. 2023;257(3):1-10. doi: 10.1530/joe-22-0232
Popescu I. Controversies in polycystic ovarian syndrome. Ginecoeu. 2017;13(1):42-45. doi: 10.18643/gieu.2017.42
Shenta A, Saud K, Al-Shawi A. Assessment the Correlations of Hormones,Lipid Profiles, Oxidative Stress, and Zinc Concentration in Iraqi Women with Polycystic Ovary Syndrome. Rep Biochem Mol Biol. 2020;9(3):270-277. doi: 10.29252/rbmb.9.3.270
Liu C, Liu K, Zhao X, et al. The Associations Between Alanine Aminotransferase and Other Biochemical Parameters in Lean PCOS. Reprod Sci. 2022;30:633-641. doi: 10.1007/s43032-022-01030-w
Grant MS. The effect of blood drawing techniques and equipment on the hemolysis of ED laboratory blood samples. J Emerg Nur. 2003;29(2):116-121. doi: 10.1067/men.2003.66
Cadamuro J, von Meyer A, Wiedemann H, et al. Hemolysis rates in blood samples: differences between blood collected by clinicians and nurses and the effect of phlebotomy training. Clin Chem Lab Med. 2016;54(12):1987-1992. doi: 10.1515/cclm-2016-0175
Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 1982;28(10):2077-2080. doi: 10.1093/clinchem/28.10.2077
Huang H, Kuan JW, Guilbault GG. Fluorometric Enzymatic Determination of Total Cholesterol in Serum. Clin Chem. 1975;21(11):1605-1608. doi: 10.1093/clinchem/21.11.1605
Assmann G, Schriewer H, Schmitz G, Hägele EO. Quantification of high-density-lipoprotein cholesterol by precipitation with phosphotungstic acid/MgCl2. Clin Chem. 1983;29(12):2026-2030. doi: 10.1093/clinchem/29.12.2026
Petrović MŽ, Cincović M, Starič J, et al. The Correlation between Extracellular Heat Shock Protein 70 and Lipid Metabolism in a Ruminant Model. Metabolites. 2021;12(1):1-14. doi: 10.3390/metabo12010019
Gordon T, Fisher M, Ernst N, Rifkind BM. Relation of diet to LDL cholesterol, VLDL cholesterol, and plasma total cholesterol and triglycerides in white adults. The Lipid Research Clinics Prevalence Study. Arteriosclerosis. 1982;2(6):502-512. doi: 10.1161/01.atv.2.6.502
Diana AL, Krishnan V, Pooja S, Manikandan V. Evaluation of the colorimetric cyanmethemoglobin method and the automatical analyser for hemoglobin estimation. SALT J Sci Res Healhc. 2021;1(1):17-27. doi: 10.56735/saltjsrh.ms2101011727
Hassan AA, Sayyah SG. Oxidative Stress Marker Malondialdehyde and Glutathione Antioxidant in Hypertensive Patients. Eur J Biomed Res. 2023;2(1):31-36. doi: 10.24018/ejbiomed.2023.2.1.47
Kolbe-Busch S, Lotz J, Hafner G, et al. Multicenter Evaluation of a Fully Mechanized Soluble Transferrin Receptor Assay on the Hitachi and Cobas Integra Analyzers. The Determination of Reference Ranges. Clin Chem Lab Med. 2002;40(5). doi: 10.1515/cclm.2002.091
Sadeghi M, Amini L, Oskuie F, Kamali K, Maleki H. Lipid Profile in Women with Polycystic Ovary Syndrome. Crescent Journal of Medical and Biological Sciences. 2014;4(1):147-150.
Keskin Kurt R, Okyay AG, Hakverdi AU, et al. The effect of obesity on inflammatory markers in patients with PCOS: a BMI-matched case–control study. Arch Gynecol Obstesity. 2014;290(2):315-319. doi: 10.1007/s00404-014-3199-3
Carmina E, Lobo RA. Polycystic Ovary Syndrome (PCOS): Arguably the Most Common Endocrinopathy Is Associated with Significant Morbidity in Women. J Clin Endocrinol Metab. 1999;84(6):1897-1899. doi: 10.1210/jcem.84.6.5803
Wild RA. Long-term health consequences of PCOS. Hum Reprod Upd. 2002;8(3):231-241. doi: 10.1093/humupd/8.3.231
Ibrahim TAES, Ali AES, Radwan MEH. Lipid Profile in Women with Polycystic Ovary Syndrome. The Egyptian Journal of Hospital Medicine. 2020;78(2):272-277. doi: 10.21608/ejhm.2020.70969
Ravi B, Swetha R, Nalini K. Serum lipoprotein(a) and lipid profile in polycystic ovarian syndrome. J Clin Sci Res. 2015;4(1):2-6. doi: 10.15380/2277-5706.jcsr.14.007
Sidhwani S, Scoccia B, Sunghay S, Stephens-Archer CN, Mazzone T, Sam S. Polycystic ovary syndrome is associated with atherogenic changes in lipoprotein particle number and size independent of body weight. Clin Endocrinol. 2011;75(1):76-82. doi: 10.1111/j.1365-2265.2011.04015.x
Bickerton AST, Clark N, Meeking D, et al. Cardiovascular risk in women with polycystic ovarian syndrome (PCOS). J Clin Path. 2005;58(2):151-154. doi: 10.1136/jcp.2003.015271
Ebrahimi-Mamaghani M, Saghafi-Asl M, Pirouzpanah S, et al. Association of insulin resistance with lipid profile, metabolic syndrome, and hormonal aberrations in overweight or obese women with polycystic ovary syndrome. J Health Popul Nutr. 2015;33(1):157-167.
Enechukwu CI, Onuegbu AJ, Olisekodiaka MJ, et al. Oxidative stress markers and lipid profiles of patients with polycystic ovary syndrome in a Nigerian tertiary hospital. Obstet Gynecol Sci. 2019;62(5):335-343. doi: 10.5468/ogs.2019.62.5.335
Dubey P, Reddy S, Boyd S, et al. Effect of Nutritional Supplementation on Oxidative Stress and Hormonal and Lipid Profiles in PCOS-Affected Females. Nutrients. 2021;13(9):2938-2951. doi: 10.3390/nu13092938
Rojas J, Chávez M, Olivar L, et al. Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth. Int J Reprod Med. 2014;2014(1):1-17. doi: 10.1155/2014/719050
Al-Akabi DF, Katab FS, Khosho EZ. Effect of Obesity on Some of Metabolic Hormones and Proinflammatory Cytokines in Patients with Polycystic Ovary Syndrome. Al-Kuno Sci J. 2021;2(1):56-65.
Mastorakos G, Koliopoulos C, Creatsas G. Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives. Fertil Steril. 2002;77(5):919-927. doi: 10.1016/s0015-0282(02)02993-x
Kempegowda P, Melson E, Manolopoulos KN, Arlt W, O’Reilly MW. Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome. Ther Adv Endocrinol Metab. 2020;11:1-24. doi: 10.1177/2042018820934319
Alvarez-Blasco F, Martínez-García MA, Luque-Ramírez M, Parraza N, San Millán JL, Escobar-Morreale HF. Role of haptoglobin in polycystic ovary syndrome (PCOS), obesity and disorders of glucose tolerance in premenopausal women. PLoS One. 2009;4(5):e5606. doi:10.1371/journal.pone.0005606
de Medeiros SF, Yamamoto MMW, Bueno HB, Belizario D, Barbosa JS. Prevalence of Elevated Glycated Hemoglobin Concentrations in the Polycystic Ovary Syndrome: Anthropometrical and Metabolic Relationship in Amazonian Women. J Clin Med Res. 2014;6(4):278-286. doi: 10.14740/jocmr1829w
Ha LX, Du YD, Qu XX, Wang JJ. Correlation Between Hemoglobin Levels and Polycystic Ovary Syndrome Metabolic Disorder. Diabetes Metab Syndr Obes. 2023;16:3019-3027. doi: 10.2147/dmso.s430120
Sabuncu T, Vural H, Harma M, Harma M. Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clin Biochem. 2001;34(5):407-413. doi: 10.1016/s0009-9120(01)00245-4
Zahoorunnisa Deba, Jambale TA, Swamy G, Murthy J. Study of levels of malondialdehyde, super oxide dismutase and hsCrp in serum of non-obese patients with polycystic ovarian syndrome. International Journal of Clinical Biochemistry and Research. 2014;4(2):191-194.
Cordiano R, Di Gioacchino M, Mangifesta R, Panzera C, Gangemi S, Minciullo PL. Malondialdehyde as a Potential Oxidative Stress Marker for Allergy-Oriented Diseases: An Update. Molecules. 2023;28(16):1-22. doi: 10.3390/molecules28165979
Sathyapalan T, Shepherd J, Coady AM, Kilpatrick ES, Atkin SL. Atorvastatin Reduces Malondialdehyde Concentrations in Patients with Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2012;97(11):3951-3955. doi: 10.1210/jc.2012-2279
Lu J, Wang Z, Cao J, Chen Y, Dong Y. A novel and compact review on the role of oxidative stress in female reproduction. Reprod Biol Endocrinol. 2018;16(1):1-18. doi: 10.1186/s12958-018-0391-5
Adamska A, Łebkowska A, Krentowska A, Adamski M, Kowalska I. The Association Between Serum Ferritin Concentration and Visceral Adiposity Estimated by Whole-Body DXA Scan in Women With Polycystic Ovary Syndrome. Front Endocrinol. 2020;10:1-8. doi: 10.3389/fendo.2019.00873
Sharifi F, Mazloomi S, Mousavinasab N. High serum ferritin concentrations in polycystic ovary syndrome is not related to insulin resistance. Iranian Journal of Diabetes and Obesityfile:///E:/ثاحبالا ةديدجلا/قاوشا دوبع/New folder/Iran J OF Dia and Obes. 2011;3(2):47-53.
Al-Hakeim HK. Correlation between Iron Status Parameters and Hormone Levels in Women with Polycystic Ovary Syndrome. Clinical Medicine Insights: Women’s Health. 2012;5:1-8. doi: 10.4137/cmwh.s8780
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
